Association of Epicardial Adipose Tissue Thickness with Left Atrial Size and Atrial Fibrillation
Cardiology and Angiology: An International Journal,
Background: Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with detrimental consequences. Epicardial fat is consistently associated with the presence, severity, and recurrence of AF.
Aim: The aim of the work was to investigate the association of epicardial adipose tissue thickness with left atrial size in patients with atrial fibrillation.
Patients and Methods: This study was conducted on 25 atrial fibrillation (AF) patients and 25 subjects with normal sinus rhythm as a control group matched in body weight. All patients underwent transthoracic echocardiogram. EAT (epicardial adipose tissue) thickness was measured on the right ventricular free wall of the two- dimensional parasternal long-axis view at end systole.
Results: The results showed that there was a significant difference between the two groups in waist circumference, EAT (epicardial adipose tissue) thickness, left atrium diameter, LA volume. Receiver operating characteristics (ROC) analysis showed that an EAT thickness of > 0.30 cm maximizes the sensitivity and specificity to predict the development of AF.
Conclusion: Increases epicardial adipose tissue is associated with the occurrence of atrial fibrillation.
- adipose tissue
How to Cite
Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clinical epidemiology. 2014;6:213.
Wong CX, Sullivan T, Sun MT, Mahajan R, Pathak RK, Middeldorp M, et al. Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies. JACC: Clinical Electrophysiology. 2015;1(3):139-52.
Lavie CJ, Pandey A, Lau DH, Alpert MA, Sanders P. Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise. Journal of the American College of Cardiology. 2017;70(16):2022-35.
Wong CX, Ganesan AN, Selvanayagam JB. Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions. European heart journal. 2016;38(17):1294-302.
McCallum CJ, Raja DC, Pathak RK. Atrial fibrillation: an update on management. Australian Prescriber. 2019;42(6):186.
Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. The Lancet. 2015;386(9989):154-62.
Yorgun H, Canpolat U, Aytemir K, Hazırolan T, Şahiner L, Kaya EB, et al. Association of epicardial and peri-atrial adiposity with the presence and severity of non-valvular atrial fibrillation. The International Journal of Cardiovascular Imaging. 2015;31(3):649-57.
Dereli S, Bayramoğlu A, Yontar OC, Cerşit S, Gürsoy MO. Epicardial fat thickness: a new predictor of successful electrical cardioversion and atrial fibrillation recurrence. Echocardiography. 2018;35(12):1926-31.
Psychari SN, Tsoukalas D, Varvarousis D, Papaspyropoulos A, Gkika E, Kotsakis A, et al. Opposite relations of epicardial adipose tissue to left atrial size in paroxysmal and permanent atrial fibrillation. SAGE open medicine. 2018; 6(20):50-58.
Haemers P, Hamdi H, Guedj K, Suffee N, Farahmand P, Popovic N, et al. Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria. European heart journal. 2017;38(1):53-61.
Abstract View: 86 times
PDF Download: 37 times